Fidelity International

Fidelity International, established in 1969, is a privately-owned global investment management firm headquartered in Bermuda. It specializes in providing investment solutions and retirement expertise to a diverse range of clients, including institutions, individuals, and their advisers. The company offers a broad spectrum of services, such as stocks and shares, personal pensions, investment accounts, advice services, wealth management, and workplace pension administration. With over $379 billion in total client assets under management, Fidelity International serves approximately 2.4 million clients across Asia Pacific, Europe, the Middle East, and South America. Its mission is to help clients build better futures for themselves and future generations by offering world-class investment solutions and long-term investment strategies.

Tony Liu

Director, Private Markets

Jed Wrigley

Director

Danny Wynn

Director - GPS Record Keeping Platforms

Derek Young

President, Japan

512 past transactions

Element Labs

Series A in 2025
Element Labs develops AI processors for inference.

Home First Finance

Post in 2025
Home First Finance Company (HFFC) specializes in providing housing finance solutions aimed at first-time buyers of affordable homes priced between Rs. 5 lakhs and Rs. 30 lakhs. The company addresses the needs of customers who often face challenges in securing loans from traditional banks and housing finance companies. HFFC offers a range of financial products, including housing loans, loans for commercial property purchases, loans against property, and construction finance. In addition to financial assistance, the company supports customers throughout the home-buying process by addressing their queries related to loan eligibility, documentation, repayment, and ownership registration, ensuring a comprehensive and supportive experience for individuals seeking to own their homes.

Nuro

Series E in 2025
Nuro, Inc. is a technology company based in Mountain View, California, that specializes in the development of self-driving vehicles specifically designed for local goods transportation. Incorporated in 2016, Nuro aims to transform local commerce through its fleet of fully autonomous, electric vehicles that facilitate the delivery of a wide range of products, including food and pharmaceuticals. By enabling retailers to efficiently and safely deliver goods to customers, Nuro enhances the convenience of local commerce and meets the growing demand for autonomous delivery solutions.

Plaid

Venture Round in 2025
Plaid Inc. is a technology company that facilitates the connection between consumers' bank accounts and applications, aiming to democratize financial services through advanced technological solutions. Founded in 2012 and headquartered in San Francisco, it provides a comprehensive suite of APIs that enable developers to create financial products connecting users with traditional financial institutions. Plaid's offerings include tools for accessing transaction history and balance data, authenticating bank accounts for payments, verifying identities, and confirming real-time account balances and income. These products support various applications in personal finances, consumer payments, lending, banking, and business finance. With a focus on enhancing both consumer experiences and developer capabilities, Plaid serves a diverse range of clients, including Fortune 50 companies, positioning itself as a vital infrastructure provider in the digital financial landscape.

Runway

Series D in 2025
Runway is an applied AI research company established in 2024, specializing in developing innovative tools that integrate artificial intelligence into creative processes. The company offers a video editing platform designed for professionals in art, entertainment, and design. Its technology leverages original image and video creation methods, allowing users to manipulate and edit content intuitively using text inputs. This approach simplifies the video creation process for artists, designers, and filmmakers, enabling them to express their creativity more effectively. Runway's mission is to enhance human creativity through advanced AI capabilities, facilitating seamless interactions between technology and artistic expression.

Retym

Series D in 2025
Retym is a semiconductor startup focused on developing innovative technologies for the data center and telecommunications sectors. The company brings together a team of experienced ASIC designers and optical communications specialists to create semiconductor solutions that enhance optical networking and digital signal processing capabilities. By prioritizing the identification and development of disruptive technologies, Retym aims to empower businesses with advanced tools for deep learning and artificial intelligence. Through its efforts, the company seeks to facilitate the construction of next-generation data centers, positioning itself as a key player in the evolution of these critical industries.

HeartFlow

Convertible Note in 2025
HeartFlow, Inc. is a medical technology company that specializes in non-invasive solutions for coronary artery disease detection. Founded in 2007 and based in Redwood City, California, with additional offices in Portland, Austin, London, and Tokyo, the company offers its HeartFlow Analysis, which utilizes data from standard computerized tomography scans to create personalized three-dimensional models of a patient's heart. This analysis helps clinicians evaluate the impact of blockages on blood flow, facilitating informed treatment decisions while minimizing the need for invasive testing. HeartFlow's technology integrates over two decades of scientific research with advancements in artificial intelligence, making its HeartFlow FFRCT Analysis available in the United States, Canada, Europe, the United Kingdom, and Japan.

Capital Markets Gateway

Series C in 2025
Capital Markets Gateway Inc. is a financial technology firm based in Chicago, Illinois, with additional locations in New York and Seattle. Founded in 2015, the company focuses on modernizing equity capital markets by providing a platform that delivers real-time information and analytics to investors, underwriters, and issuers. This platform enables users to monitor capital raising activities, conduct due diligence, and make informed investment decisions while facilitating collaboration among participants. Since its launch in 2017, Capital Markets Gateway has garnered the trust of over 100 buy-side firms, managing a combined $20 trillion in assets under management, along with support from 10 investment banks. The platform emphasizes transparency and workflow efficiencies, serving as a digital system of record for firm-wide deal activity.

Celestial AI

Series C in 2025
Celestial AI is a prominent artificial intelligence company that provides an advanced platform for users to efficiently create images, text, and presentations. Utilizing computer vision algorithms and natural language processing, the platform produces high-quality visual and textual content. Its intuitive design and innovative features simplify the creation process, while intelligent data integration and a commitment to security ensure reliable results.

Anthropic

Series E in 2025
Anthropic is an artificial intelligence research company dedicated to enhancing the safety and reliability of AI systems. The firm focuses on developing large-scale AI models that are interpretable, steerable, and aligned with human values. Its research encompasses various areas, including natural language processing, human feedback, scaling laws, reinforcement learning, and code generation. The company aims to produce AI systems that prioritize transparency and safety, enabling clients to better understand both the opportunities and risks associated with artificial intelligence. Anthropic's initial product, Claude, serves as an AI assistant designed for a range of tasks, reflecting the company's commitment to creating trustworthy AI solutions.

Amaero International

Post in 2025
Amaero International is an Australian company that specializes in manufacturing complex metal components through laser-based additive manufacturing processes. Established in 2013 and headquartered in Notting Hill, the company produces high-temperature powder metals and specialty alloys, including refractory and titanium powders, using advanced technologies like gas atomization and hot isostatic pressing. Amaero serves various sectors, including aviation, defense, space, energy, and medical, providing services such as research and development, contract manufacturing, design and prototyping, as well as equipment sales and training. The company has formed a strategic partnership with the University of Adelaide to further advance additive manufacturing in South Australia.

Saluda Medical

Venture Round in 2025
Saluda Medical, established in 2010, is a global medical device company specializing in neuromodulation technologies. Headquartered in Australia with offices in the US and UK, the company develops and commercializes innovative, closed-loop spinal cord stimulation systems. These systems measure and adapt to the spinal cord's response to stimulation, optimizing therapy within each patient's unique therapeutic window. Saluda's primary focus is treating chronic neuropathic pain, with its devices designed to automatically adjust electrical stimulation based on real-time neurophysiological feedback, tailoring treatment to individual patient needs.

Tenstorrent

Series D in 2024
Tenstorrent Inc. is a Canadian company that develops and manufactures application-specific integrated circuits (ASIC) focused on artificial intelligence and machine learning. Founded in 2016 and headquartered in Toronto, with an additional office in Austin, Texas, Tenstorrent specializes in providing scalable and efficient hardware solutions for various applications, ranging from battery-powered Internet of Things (IoT) devices to large cloud servers. The company’s architecture supports deep learning and enables adaptability in algorithms, catering to developers and researchers in the technology sector. By offering advanced AI hardware and software, Tenstorrent aims to enhance computational performance and facilitate the growth of machine learning technologies.

Boosted.ai

Venture Round in 2024
Boosted.ai is an artificial intelligence company focused on improving portfolio management for the global financial industry through advanced machine learning techniques. Its web-based platform, Boosted Insights, allows portfolio managers to leverage sophisticated quantitative investing strategies without necessitating coding or data science expertise. By providing tools that automate and simplify the investment decision-making process, Boosted.ai enables financial professionals to conduct deep analyses of market data, thereby enhancing their ability to make informed investment choices. The company's innovative approach aims to increase returns for portfolio managers and financial firms, making advanced investment strategies accessible to a wider audience.

Oura

Series D in 2024
Oura is a Finnish company that specializes in the development of a smart wellness ring designed to monitor and track various biometric data related to health and well-being. The ring incorporates advanced sensors to measure key metrics such as heart rate, sleep cycles, and activity levels, providing users with insights into their physiological and behavioral responses to sleep, rest, and recovery. This data is accessible through the accompanying Oura application, which enables users to understand their overall health status and make informed lifestyle choices. Oura operates within the health and wellness industry, focusing on enhancing the user's understanding of their body and promoting better health outcomes.

CoreWeave

Secondary Market in 2024
CoreWeave is a company that specializes in developing a cloud infrastructure platform aimed at providing powerful computing resources for artificial intelligence/machine learning (AI/ML) projects and other initiatives. Their platform features a specialized GPU cloud system designed to accelerate workflows by matching the complexity of models, allowing clients to scale efficiently and adapt to rapidly changing compute requirements. This enables clients to design and innovate with various types of compute resources tailored to their specific needs.

BETA Technologies

Series C in 2024
Beta Technologies specializes in the design and development of electric aircraft, including advanced flight control and electric propulsion systems, with a strong emphasis on clean aviation technology. The company aims to establish a new paradigm for transporting goods and people through its self-sufficient electric vertical takeoff and landing (eVTOL) aircraft ecosystem. This ecosystem is designed to meet human mobility needs while adhering to environmental principles. Additionally, Beta Technologies is working on a comprehensive electric transportation system that features net-zero, all-electric aircraft and a multimodal charging infrastructure to support various electric vehicles. The company also offers training programs for pilots and maintenance personnel, catering to clients in the cargo, passenger, and emergency response sectors, and enabling them to implement more efficient, cleaner, and faster transportation solutions.

Crusoe Energy Systems

Series D in 2024
Crusoe Energy Systems Inc., based in Denver, Colorado, develops innovative technology and solutions aimed at addressing operational, environmental, and regulatory challenges in the oil and gas sector. Founded in 2018, the company specializes in its Digital Flare Mitigation solution, which allows upstream operators without pipeline access to convert wasted natural gas into electricity for energy-intensive computing. This service not only helps oil and gas producers reduce routine flaring of natural gas but also assists them in achieving regulatory compliance and maintaining production levels amid increasing regulations and pipeline constraints. Crusoe Energy Systems is committed to creating solutions that benefit the environment, local communities, and energy producers alike.

Lightmatter

Series D in 2024
Lightmatter, Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in developing AI hardware using integrated optical technology. The company's core product is a silicon chip that processes data using light signals instead of electrical signals, aiming to significantly accelerate AI computations. Lightmatter targets sectors such as artificial intelligence, cloud computing, and telecommunications, with a focus on improving efficiency and reducing power consumption in critical operations like image recognition and natural language processing.

Wolfspeed

Post in 2024
Wolfspeed is a leading manufacturer specializing in wide bandgap semiconductors, particularly silicon carbide (SiC) and gallium nitride (GaN) materials and devices. The company plays a crucial role in the transformation of the semiconductor industry, supporting the transition to electric vehicles, the deployment of faster 5G networks, and advancements in renewable energy and energy storage systems. Wolfspeed offers a range of products designed for power and radio-frequency applications, including use in transportation, power supplies, inverters, and wireless systems. With a workforce of over 550 skilled employees, the company boasts a robust intellectual property portfolio of approximately 2,000 patents and patent applications. Its operations are primarily based in Europe, with additional revenue derived from the United States, China, Hong Kong, and other regions.

City Therapeutics

Series A in 2024
City Therapeutics is a biopharmaceutical company specializing in the development of next-generation small-interfering RNAs (siRNAs) to enhance RNA interference (RNAi) therapies. The company's pipeline comprises innovative RNAi therapeutics targeting diverse disease indications. City Therapeutics aims to improve and expand RNAi technology to achieve better patient outcomes, led by a team of experienced scientists and industry professionals committed to advancing the field of RNA interference.

Triveni Bio

Series B in 2024
Triveni Bio is a biotechnology company specializing in the development of novel antibody therapies for immunological and inflammatory disorders. The company employs a genetics-driven precision medicine approach to identify patients most likely to respond to its treatments, aiming to accelerate drug development and improve the effectiveness and safety of therapies.

OpenAI

Venture Round in 2024
OpenAI is an artificial intelligence research and deployment company focused on developing machine learning technologies that aim to create safe artificial general intelligence for the benefit of all users. The company engages in projects related to autonomous learning and task performance across various industries, including technology, healthcare, and education. OpenAI's platform directs artificial intelligence applications and is involved in policy work, education, and outreach, enabling clients to enhance their skills and knowledge while leveraging autonomous systems that can surpass human performance in economically valuable tasks.

PNB Housing Finance

Post in 2024
PNB Housing Finance Limited is a housing finance company based in New Delhi, India, established in 1988. The company specializes in providing a variety of loans, including housing loans for the purchase, construction, repair, and renovation of residential and commercial properties. It also offers loans against property, loans for the purchase of residential plots, and financing for commercial spaces. PNB Housing Finance caters to different customer segments, including non-resident Indians and individuals from economically weaker sections and lower to middle-income groups through various schemes. In addition to home loans, the company provides non-home loans, such as mortgage loans for residential and commercial properties, lease rental discounting loans, and financing for real estate developers. PNB Housing Finance generates revenue primarily through interest income and fees from its diverse lending services.

Anduril Industries

Series F in 2024
Anduril Industries, Inc. is a defense technology company that designs, manufactures, and deploys advanced hardware and software products to address complex national security challenges faced by the United States and its allies. Founded in 2017 and headquartered in Irvine, California, with additional offices in Washington, D.C., and Seattle, the company employs top technical talent to create innovative solutions. Its offerings include the Lattice Platform, which integrates artificial intelligence, computer vision, and machine learning to provide a cohesive operational picture; the Sentry Tower, which collects data across the electromagnetic spectrum; and the Ghost sUAS, a man-portable unmanned aerial system capable of performing various missions autonomously. Additionally, Anduril develops the Anvil sUAS, designed for precise drone threat interception while providing visual feedback for human operators. Through its cutting-edge technology, Anduril aims to enhance defense capabilities and support frontline personnel in safeguarding national interests.

Applied Intuition

Secondary Market in 2024
Applied Intuition, Inc. is a company that creates software infrastructure to facilitate the safe development, testing, and deployment of autonomous vehicles at scale. Founded in 2017 and headquartered in Sunnyvale, California, the company also maintains offices in Silicon Valley and Detroit, Michigan. Its advanced simulation infrastructure software offers a comprehensive suite of products focused on simulation and analytics, enabling automotive industries to thoroughly test and expedite the development of their autonomous vehicle technologies. By providing sophisticated tools designed for scalability, Applied Intuition supports the automotive sector in navigating the complexities of autonomous vehicle deployment effectively.

Waymo

Series C in 2024
Waymo is a self-driving technology company focused on enhancing mobility by creating safe and efficient transportation solutions. Established from advancements in Google's research since 2009, Waymo aims to improve the movement of people and goods through its innovative software and sensor technology. In 2015, the company marked a significant milestone by conducting the world's first fully autonomous trip on public roads in a vehicle devoid of traditional driving controls. Waymo continually refines its technology through extensive simulation testing, accumulating over one billion miles of virtual testing annually, while its autonomous vehicles have logged more than two million miles on public roads in four U.S. cities. By employing integrated sensors and artificial intelligence, Waymo's technology is designed to detect various obstacles such as pedestrians, cyclists, and road conditions, ensuring a safe and convenient on-demand travel experience for users.

Frore Systems

Series C in 2024
Frore Systems is a technology company based in San Jose, California, with additional offices in Taiwan and South Korea. It specializes in the development of advanced thermal solutions for consumer devices, focusing on active cooling technologies. The company's flagship products, AirJet® Mini and AirJet® Pro, utilize piezoelectric MEMS technology to provide efficient and silent heat dissipation. These cooling chips significantly enhance device performance and offer a solid-state alternative to traditional fans, setting new benchmarks for the computing industry. Frore Systems aims to improve the overall user experience by enabling device manufacturers to implement high-performance cooling solutions in their products.

CoreWeave

Series C in 2024
CoreWeave is a company that specializes in developing a cloud infrastructure platform aimed at providing powerful computing resources for artificial intelligence/machine learning (AI/ML) projects and other initiatives. Their platform features a specialized GPU cloud system designed to accelerate workflows by matching the complexity of models, allowing clients to scale efficiently and adapt to rapidly changing compute requirements. This enables clients to design and innovate with various types of compute resources tailored to their specific needs.

PSP Projects

Post in 2024
PSP Projects Ltd is a multidisciplinary construction company based in India, specializing in a wide array of construction and allied services. The company serves various sectors, including industrial, institutional, government, residential, and government residential projects. It operates within a single segment focused on construction project activities, offering comprehensive services that encompass the entire construction value chain—from planning and design to construction and post-construction activities. By catering to both private and public sector enterprises, PSP Projects aims to deliver quality and efficiency in its projects throughout India.

Vodafone Idea

Post in 2024
Vodafone Idea is a prominent Indian telecommunications operator that offers comprehensive voice and data services across the country. Formed through the merger of Vodafone India and Idea Cellular, the company primarily focuses on mobility services, which represent the majority of its revenue. Vodafone Idea owns essential telecommunications infrastructure, including fiber networks and mobile towers, enabling it to deliver reliable mobile services to its customers. The company's operations are predominantly centered in India, where it plays a significant role in the telecommunications sector.

SiMa.ai

Series C in 2024
SiMa.ai is a company based in San Jose, California, focused on designing and developing a machine learning platform that provides a single-chip solution for embedded systems. The company specializes in machine learning system-on-chip (MLSoC) technology, which allows for high-performance machine learning inference at low power in edge applications. SiMa.ai's platform enables seamless deployment and scaling of machine learning solutions, addressing various computer vision challenges with significantly improved performance and energy efficiency. The hardware-to-software stack of SiMa.ai is adaptable to multiple frameworks and models, enhancing the capabilities of applications in areas such as computer vision and generative AI. Founded in 2018, SiMa.ai aims to facilitate the integration of advanced machine learning technology into embedded systems while ensuring safe and secure operations.

MMI

Series C in 2024
MMI S.r.l. is an Italian company that specializes in the manufacture and development of advanced micro instruments designed for surgical interventions. Founded in 2015 and based in Calci, Italy, MMI focuses on creating wristed micro instruments and their associated fabrication processes. The company also offers a proprietary robotic platform that enhances the capabilities of these instruments, facilitating complex reconstruction procedures following traumatic injuries and tumor removals in areas such as the breast, head, and bones. MMI aims to support surgeons globally by providing innovative tools that improve surgical outcomes while also reducing costs for patients and healthcare systems.

Axis Bank

Post in 2023
Axis Bank, established in 1994 and headquartered in Mumbai, India, is the third largest private sector bank in the country. The bank offers a wide range of financial products and services, including personal loans, car loans, savings accounts, credit cards, education loans, trade and forex services, and internet banking. It has expanded its international presence with eight offices located in key global financial centers, including Singapore and Dubai, and a subsidiary in London. These international offices primarily focus on corporate lending, trade finance, syndication, investment banking, and liability businesses. Over the years, Axis Bank has shown consistent growth and stable asset quality, positioning itself as a significant player in the Indian banking sector.

VAST Data

Series E in 2023
VAST Data, Inc. specializes in developing innovative data storage solutions, offering a universal storage platform that integrates Intel’s Optane SSDs as a cache for data stored on quad-level cell (QLC) SSDs. Founded in 2016 and headquartered in New York, with an additional office in San Jose, VAST Data serves various industries, including animation, visual effects, deep learning, and enterprise backup recovery. The platform is designed to accelerate time-to-insight for workload-intensive applications, providing scalable performance, simple data management, and improved productivity for AI-driven organizations. Since its launch in 2019, VAST Data has gained recognition as a rapidly growing player in the data infrastructure sector.

CoreWeave

Secondary Market in 2023
CoreWeave is a company that specializes in developing a cloud infrastructure platform aimed at providing powerful computing resources for artificial intelligence/machine learning (AI/ML) projects and other initiatives. Their platform features a specialized GPU cloud system designed to accelerate workflows by matching the complexity of models, allowing clients to scale efficiently and adapt to rapidly changing compute requirements. This enables clients to design and innovate with various types of compute resources tailored to their specific needs.

Zomato

Post in 2023
Zomato is a global online platform that connects over 55 million users with restaurants across 24 countries. It offers a comprehensive restaurant guide, enabling users to discover, rate, and review eateries, as well as order meals for delivery or table reservations. The company also provides advertising and ingredient supply services to its restaurant partners.

Iperionx

Post in 2023
IperionX is a developer of sustainable titanium metal and critical materials, focusing on advanced industries such as aerospace, space, electric vehicles, and 3D printing. The company employs patented technologies to produce high-performance titanium alloys from titanium minerals and scrap while minimizing energy consumption, costs, and carbon emissions. IperionX operates a pilot facility in Utah that produces titanium metal powders from scrap, showcasing its commitment to low-carbon manufacturing. Additionally, the company holds the Titan Project in Tennessee, which encompasses over 11,000 acres of mineral resources, including titanium, rare earth elements, silica sand, and zircon. These materials are vital for various U.S. industries, including defense and consumer electronics, aligning with the country’s goals for sustainable and advanced material supply chains.

SHINE Technologies

Convertible Note in 2023
SHINE Technologies, LLC is a medical technology company that specializes in the production and supply of medical tracers and cancer treatment elements. It primarily manufactures and distributes molybdenum-99 (moly-99), a key isotope used in the diagnosis and staging of various diseases, including cancer and heart disease. Additionally, SHINE offers iodine-131 and iodine-125 for treating thyroid cancer and other abnormal thyroid conditions, as well as for diagnosing liver function, kidney blood flow, and urinary tract obstruction. The company also provides xenon-133 for evaluating lung function and blood flow, particularly in the brain. SHINE's products are used extensively in the United States and internationally. Founded in 2010, the company is headquartered in Janesville, Wisconsin, with an additional office in Alkmaar, the Netherlands.

AgomAb Therapeutics

Series C in 2023
AgomAb Therapeutics N.V., based in Gent, Belgium, specializes in the development of molecular therapies aimed at regenerating damaged tissues. The company focuses on creating agonistic monoclonal antibodies, known as agomAbs, which are designed to stimulate molecular and cellular repair mechanisms. These therapies have the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative diseases. AgomAb targets biologically validated pathways, including Transforming Growth Factor β and Hepatocyte Growth Factor, while employing specialized capabilities in organ-specific small molecules and high-affinity antibodies. The company boasts a diversified clinical pipeline addressing various fibrotic conditions and possesses comprehensive research and development expertise, alongside a strong track record in business development.

Evozyne

Series B in 2023
Evozyne, LLC is a biotechnology company based in Chicago, Illinois, focused on protein design and molecular engineering. Founded in 2020, it utilizes a generative AI platform to create novel proteins with advanced functionality, addressing complex human and societal challenges. The company operates multiple business units, including Evozyne Industrial, Evozyne Agriculture, Evozyne Energy, Evozyne Biopharmaceuticals, and Evozyne Environmental. Its technology provides consistent models for protein behavior, enabling the development of customized proteins that can address various health-related issues and improve industrial processes. By revolutionizing protein design, Evozyne aims to unlock the potential of proteins in therapeutic discovery and drug development.

Generate Biomedicines

Series C in 2023
Generate Biomedicines, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies through its unique platform. The company specializes in Generative Biology, a machine learning-driven approach that analyzes known proteins to understand the relationship between genetic sequences, protein structure, and function. This enables the creation of novel therapeutic proteins, including antibodies, enzymes, and receptors, which are designed to interact specifically and effectively with various therapeutic targets. Founded in 2018 and rebranded from Generate Biologics in 2020, Generate Biomedicines aims to streamline the drug discovery process by generating new biological molecules with significant therapeutic potential.

Rapport Therapeutics

Series B in 2023
Rapport Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing innovative small-molecule therapies for neurological disorders. The company focuses on understanding the intricate biology of neuronal receptor complexes, which are essential for proper neuronal function and signaling. By mapping and targeting these receptor systems, Rapport Therapeutics aims to create precision medicines that can effectively address the unmet needs of patients suffering from central nervous system disorders. Through its foundational research, the company seeks to transform treatment options and improve outcomes for individuals with these challenging conditions.

Genesis Therapeutics

Series B in 2023
Genesis Therapeutics Inc. is a biotechnology company based in South San Francisco, California, that focuses on developing small molecule drug candidates aimed at treating patients with severe and debilitating disorders. Established in 2019, the company harnesses a proprietary artificial intelligence platform that employs advanced deep neural networks and biophysical simulation techniques to enhance drug discovery and molecular design. By combining these innovative technologies with a scalable computing infrastructure, Genesis Therapeutics aims to improve the efficiency and accuracy of molecular research. This approach not only facilitates the generation and analysis of novel drug candidates but also holds the potential to significantly advance clinical outcomes in the medical community.

GenePlanet

Series B in 2023
GenePlanet is a European biotechnology company that focuses on genetic testing and research. It offers a range of preventive genetic tests aimed at consumers, as well as clinical genetic tests that assist healthcare professionals in therapeutic decision-making. Their tests are based on the latest scientific advancements and adhere to high-quality standards. By utilizing saliva-based DNA testing, GenePlanet provides individuals with personalized insights into their genetic predispositions, allowing them to make informed lifestyle adjustments to mitigate health risks. This approach encourages improved health, vitality, and overall well-being through tailored prevention programs.

Moloco

Secondary Market in 2023
Moloco Inc., founded in 2013 and based in Palo Alto, California, specializes in programmatic advertising solutions aimed at optimizing client acquisition, retention, and monetization strategies. The company offers a cloud-based demand-side platform that leverages machine learning to help businesses of all sizes enhance user acquisition and maximize lifetime value through predictive models. Additionally, Moloco provides a mobile e-commerce platform that supports targeted re-engagement campaigns, allowing application publishers and e-commerce platforms to expand their customer reach more effectively than traditional advertising methods. With a team comprised of top talents from leading tech firms, Moloco is committed to empowering mobile businesses to thrive in a competitive landscape.

Aledade

Series F in 2023
Aledade, Inc. is a company that supports primary care physicians in establishing and managing accountable care organizations (ACOs) across the United States. Founded in 2014 and headquartered in Bethesda, Maryland, Aledade provides a comprehensive suite of services including data analytics, guided workflows, regulatory expertise, and payer relationships. The company aims to empower independent primary care providers by offering customized solutions, operational support, and advanced technology to enhance practice efficiency and patient care. Aledade serves a diverse range of healthcare practices, including small and large practices, community health centers, and multispecialty groups. By facilitating better care delivery and reducing overall costs, Aledade helps physicians maintain their independence while improving health outcomes for their patients.

Lightmatter

Series C in 2023
Lightmatter, Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in developing AI hardware using integrated optical technology. The company's core product is a silicon chip that processes data using light signals instead of electrical signals, aiming to significantly accelerate AI computations. Lightmatter targets sectors such as artificial intelligence, cloud computing, and telecommunications, with a focus on improving efficiency and reducing power consumption in critical operations like image recognition and natural language processing.

Saluda Medical

Venture Round in 2023
Saluda Medical, established in 2010, is a global medical device company specializing in neuromodulation technologies. Headquartered in Australia with offices in the US and UK, the company develops and commercializes innovative, closed-loop spinal cord stimulation systems. These systems measure and adapt to the spinal cord's response to stimulation, optimizing therapy within each patient's unique therapeutic window. Saluda's primary focus is treating chronic neuropathic pain, with its devices designed to automatically adjust electrical stimulation based on real-time neurophysiological feedback, tailoring treatment to individual patient needs.

Shoobx

Acquisition in 2023
Financing-Ready at Every Turn. Shoobx is reshaping how private companies get started, raise capital, and exit by raising the bar for cap table management and making venture financing simpler. Everything You Need to Scale and Exit - Fundraise faster than ever before - Have more accurate data and documentation - Automate your legal operations Thousands of users, investors, and attorneys rely on Shoobx to get paperwork right the first time and make legal diligence easy and fast. Automated your next round at shoobx.com.

Asimov

Series B in 2023
Asimov, Inc. is a biotechnology company that specializes in the design and development of genetically engineered therapeutics. Established in 2017 and based in Cambridge, Massachusetts, Asimov focuses on creating tools for programming living cells to enhance the design and manufacturing processes of biologics and gene therapies. The company's platform integrates synthetic biology, computer-aided design, and machine learning, allowing for the engineering of genetic circuits. Asimov's multidisciplinary team employs machine-learning algorithms that connect large-scale datasets with biological models, facilitating advancements in molecular manufacturing and therapeutic applications. The company is dedicated to optimizing the production of protein biologics, viral vectors, and cell and gene therapies.

Apogee Therapeutics

Series B in 2022
Apogee Therapeutics is a biotechnology company based in San Francisco, California, founded in 2022. The company focuses on developing differentiated biologics for the treatment of immunological and inflammatory disorders, specifically targeting atopic dermatitis and chronic obstructive pulmonary disease. Apogee Therapeutics aims to address high unmet medical needs by advancing novel therapies that utilize advanced antibody engineering to enhance therapeutic properties such as half-life. The company's key programs, APG777 and APG808, are designed to leverage established mechanisms of action to improve treatment outcomes for patients suffering from these conditions.

Fanatics

Private Equity Round in 2022
Fanatics, Inc. is a leading global e-commerce company specializing in licensed sports merchandise, including fan gear and jerseys. Founded in 1995 and headquartered in Jacksonville, Florida, the company operates a multi-channel retail platform that serves professional sports leagues, media brands, and collegiate teams. Fanatics designs, manufactures, and distributes its products across various channels, including online, mobile, and physical stores, catering to the evolving needs of sports fans in a mobile-first, on-demand culture. The company has additional offices in San Mateo, California, and Manchester, United Kingdom, and aims to enhance the shopping experience by providing a wide range of products that meet the real-time expectations of customers.

FogPharma

Series D in 2022
FogPharma is a biotechnology company focused on developing innovative cancer therapies through its unique cell-penetrating mini proteins (CPMPs). Founded by Greg Verdine, the company aims to address cancer-causing proteins that are typically inaccessible to traditional treatments. By collaborating with leading experts in cancer biology and therapy, FogPharma is creating a new class of medicines designed to neutralize these challenging targets. The company is supported by a diverse group of private and institutional investors, which enables it to pursue its mission of delivering transformative cancer treatments. FogPharma is dedicated to improving the lives of patients and their families, striving to extend both life expectancy and quality of life.

Astera Labs

Series D in 2022
Astera Labs is a fabless semiconductor company based in Santa Clara, California, established in 2017. The company specializes in designing and supplying semiconductors and connectivity solutions tailored for data-centric systems. Its product range includes system-aware semiconductor integrated circuits, high-speed mixed-signal connectivity products, and various system components like PCIe smart retimers, riser cards, and GPU booster cards. Astera Labs focuses on enhancing PCIe connectivity to address performance bottlenecks in compute-intensive environments, such as server connectivity, distributed machine learning, and high-end gaming graphics. The company collaborates with processor vendors, cloud service providers, and manufacturing partners to deliver critical connectivity performance and facilitate flexibility and customization in their clients' systems. Astera Labs also offers design and testing services, alongside its COSMOS software suite, which enhances observability and predictive analytics in connectivity solutions.

Emalex Biosciences

Series D in 2022
Emalex Biosciences is a biotechnology startup focused on developing innovative treatments for central nervous system (CNS) disorders and rare neurological conditions. Founded in 2018 by Jeff Aronin, the company is advancing its lead candidate, Ecopipam, which has been explored as a potential therapy for various CNS disorders, including pediatric Tourette Syndrome and fluency disorders. Emalex aims to address the needs of patients with rare diseases that currently have limited or no treatment options, collaborating with patient advocacy organizations and medical researchers to facilitate the development of effective biopharmaceutical therapies.

SiMa.ai

Series B in 2022
SiMa.ai is a company based in San Jose, California, focused on designing and developing a machine learning platform that provides a single-chip solution for embedded systems. The company specializes in machine learning system-on-chip (MLSoC) technology, which allows for high-performance machine learning inference at low power in edge applications. SiMa.ai's platform enables seamless deployment and scaling of machine learning solutions, addressing various computer vision challenges with significantly improved performance and energy efficiency. The hardware-to-software stack of SiMa.ai is adaptable to multiple frameworks and models, enhancing the capabilities of applications in areas such as computer vision and generative AI. Founded in 2018, SiMa.ai aims to facilitate the integration of advanced machine learning technology into embedded systems while ensuring safe and secure operations.

Local Bounti

Post in 2022
Local Bounti is an agriculture company based in Hamilton, Montana, focused on controlled environment agriculture. Established in 2018, it specializes in producing and delivering fresh herbs, vegetables, and other products primarily to wholesale restaurant and grocery accounts. The company employs proprietary technology to cultivate leafy greens and herbs in innovative greenhouses, which maintain optimal conditions for growth while using less water and land than traditional farming methods. Local Bounti's products are non-GMO, free from herbicides and pesticides, and are designed to have a longer shelf life and superior taste. By building local facilities operated by local teams, the company aims to serve its communities while minimizing its carbon footprint and environmental impact.

Wasabi

Series D in 2022
Wasabi Technologies, Inc. is a Boston-based company that offers a cloud storage platform tailored for hybrid and multi-cloud media workflows. Founded in 2016, Wasabi provides hot storage solutions that utilize an Amazon S3 compatible API, enabling organizations to store and access data quickly, with average time-to-first-byte speeds under 15 milliseconds. The company's platform is designed to be simple and affordable, allowing customers to access unlimited data without complex pricing tiers or unpredictable egress fees. Wasabi's services cater to various industries, including media and entertainment, education, scientific research, law enforcement, healthcare, and energy. The company has gained recognition for its rapid growth and innovative approach to cloud storage, serving tens of thousands of customers worldwide.

Galvanize Therapeutics

Series B in 2022
Galvanize Therapeutics is a medical technology company specializing in energy-based devices aimed at improving biological processes for therapeutic applications. Founded in 2022 by Apple Tree Partners, the company focuses on developing innovative solutions to treat various medical conditions, including chronic bronchitis, cardiac arrhythmias, and solid tumors. Its platform employs short-duration, high-voltage electrical pulses to create electric fields that destabilize cells through multiple biochemical mechanisms. This technology enhances the ability of medical professionals to provide effective healthcare services, positioning Galvanize Therapeutics as a potential leader in delivering cutting-edge medical innovations.

Study Plus

Series D in 2022
Study Plus is an educational application that focuses on enhancing collaborative studying among students. It operates as a learning management platform, helping users adopt a systematic approach to their studies. The platform enables students to record their study times, subjects, and content, while also allowing them to share this information through social networks. By facilitating organization and collaboration, Study Plus aims to support students in completing their syllabus efficiently and effectively.

Aledade

Series E in 2022
Aledade, Inc. is a company that supports primary care physicians in establishing and managing accountable care organizations (ACOs) across the United States. Founded in 2014 and headquartered in Bethesda, Maryland, Aledade provides a comprehensive suite of services including data analytics, guided workflows, regulatory expertise, and payer relationships. The company aims to empower independent primary care providers by offering customized solutions, operational support, and advanced technology to enhance practice efficiency and patient care. Aledade serves a diverse range of healthcare practices, including small and large practices, community health centers, and multispecialty groups. By facilitating better care delivery and reducing overall costs, Aledade helps physicians maintain their independence while improving health outcomes for their patients.

SiMa.ai

Series B in 2022
SiMa.ai is a company based in San Jose, California, focused on designing and developing a machine learning platform that provides a single-chip solution for embedded systems. The company specializes in machine learning system-on-chip (MLSoC) technology, which allows for high-performance machine learning inference at low power in edge applications. SiMa.ai's platform enables seamless deployment and scaling of machine learning solutions, addressing various computer vision challenges with significantly improved performance and energy efficiency. The hardware-to-software stack of SiMa.ai is adaptable to multiple frameworks and models, enhancing the capabilities of applications in areas such as computer vision and generative AI. Founded in 2018, SiMa.ai aims to facilitate the integration of advanced machine learning technology into embedded systems while ensuring safe and secure operations.

Vention

Series C in 2022
Vention Inc. is a digital manufacturing platform based in Montreal, Canada, that simplifies the design and ordering of custom machines. Established in 2016, the company provides a cloud-based 3D Machine Builder, which allows engineers and manufacturing professionals to design, order, and assemble custom factory equipment quickly. This platform features an extensive library of modular parts, including structural, motion, and control components, facilitating the creation of automated equipment, robot cells, tooling, and conveyors. Additionally, Vention's offerings include MachineMotion, which aids both automation specialists and novices in automating their designs. By integrating artificial intelligence to enhance the design process, Vention enables users to program, simulate, and commission automated equipment within a single digital environment, making industrial automation more accessible.

X (formerly Twitter)

Post in 2022
Twitter is a social networking platform that facilitates the exchange of micro-blogs, known as "tweets," which can be up to 280 characters in length. Launched in 2006, it allows users to send and read tweets through various means, including web browsers, SMS, and mobile applications. With over 400 million monthly visitors and 255 million active users, Twitter serves as a global real-time communications platform. Its diverse user base includes world leaders, athletes, entertainers, and news organizations, contributing to its role as a significant source of information and engagement. The platform is available in more than 35 languages and has a strong presence in major cities worldwide, with headquarters in San Francisco and offices across the United States and internationally.

Castle Creek Biosciences

Venture Round in 2022
Castle Creek Biosciences, Inc. is a gene therapy company headquartered in Exton, Pennsylvania, that specializes in developing and commercializing personalized gene therapies for rare skin and connective tissue disorders. Founded in 2015, the company utilizes a fibroblast technology platform that extracts fibroblast cells from a patient's own skin to create localized therapies tailored to the individual’s unique biology. This innovative approach aims to address the underlying causes of diseases that currently have high unmet medical needs, ultimately improving the lives of patients suffering from these underserved conditions.

Starling Bank

Series D in 2022
Starling Bank Limited is a digital-only bank based in London, United Kingdom, founded in 2014. It specializes in providing personal, joint, and business banking services through a mobile platform. The bank offers a range of financial services, including digital banking, real-time spending intelligence, and personalized banking options. Customers can manage their accounts entirely online, benefiting from features such as same-day payments and comprehensive financial management tools. Starling Bank aims to facilitate a seamless, paperless banking experience for its users.

BETA Technologies

Series B in 2022
Beta Technologies specializes in the design and development of electric aircraft, including advanced flight control and electric propulsion systems, with a strong emphasis on clean aviation technology. The company aims to establish a new paradigm for transporting goods and people through its self-sufficient electric vertical takeoff and landing (eVTOL) aircraft ecosystem. This ecosystem is designed to meet human mobility needs while adhering to environmental principles. Additionally, Beta Technologies is working on a comprehensive electric transportation system that features net-zero, all-electric aircraft and a multimodal charging infrastructure to support various electric vehicles. The company also offers training programs for pilots and maintenance personnel, catering to clients in the cargo, passenger, and emergency response sectors, and enabling them to implement more efficient, cleaner, and faster transportation solutions.

Dianthus Therapeutics

Series A in 2022
Dianthus Therapeutics is a clinical-stage biotechnology company focused on developing innovative treatments for severe autoimmune diseases through targeted therapies. The company's lead candidate, DNTH103, is a monoclonal antibody designed to selectively inhibit a specific component of the immune system, offering potential advantages over existing complement therapies. This treatment aims to improve safety and efficacy for patients suffering from serious autoimmune and inflammatory conditions. Dianthus is committed to advancing its pipeline of next-generation complement therapeutics, supported by a team of experienced professionals in the biotech and pharmaceutical sectors. The company envisions that DNTH103 could be administered as a self-injection for certain patients, enhancing convenience and accessibility in treatment.

Circle

Private Equity Round in 2022
Circle is a financial technology firm established in 2013 by Jeremy Allaire and Sean Neville, headquartered in Boston, with additional offices in New York, San Francisco, Dublin, London, and Hong Kong. The company leverages blockchain technology to facilitate payments and e-commerce through stablecoins and its Circle Pay platform, streamlining the process of sending money. Circle offers a range of services, including Circle Invest, which allows users to buy and sell cryptocurrency assets, and Circle Trade, which provides over-the-counter trading services with access to one of the largest global liquidity pools for digital asset trading, averaging $2 billion in monthly volume. Backed by prominent investors such as Goldman Sachs and Accel Partners, Circle positions itself as a key player in the global internet finance sector, focused on integrating crypto assets into mainstream financial applications.

Coin Metrics

Series C in 2022
Coin Metrics Inc. is a provider of blockchain and cryptocurrency data analytics, based in Cambridge, Massachusetts. Founded in 2017, the company specializes in delivering market and network data, analytics, and research to various industries and institutions involved in crypto-assets. Its offerings include the CM Network Data Pro, which provides comprehensive historical data on top cryptocurrency assets, and the CM Market Data Feed, which standardizes trade, candle, and order book data from multiple exchanges. Additionally, Coin Metrics offers CM Reference Rates, which present fixed asset pricing in U.S. dollars. By focusing on transparency and actionable data, Coin Metrics aims to empower individuals and organizations to make informed financial decisions related to cryptocurrencies.

Rapyd

Secondary Market in 2022
Rapyd is a payments platform that integrates fintech services into applications, streamlining access to a variety of local payment methods. It empowers e-commerce merchants, gig platforms, challenger wallets, remittance services, online lenders, and traditional banks to overcome the constraints of outdated infrastructure. By facilitating the creation of innovative, mobile-friendly payment solutions, Rapyd enhances the financial capabilities of its users, allowing them to adapt to the evolving demands of the digital economy.

Starry

Post in 2022
Starry, Inc. is an innovative internet company headquartered in Boston, Massachusetts, with operations in New York, New York. Founded in 2014, the company specializes in user-friendly Wi-Fi products and high-speed broadband internet services. Starry's flagship product, the Starry Station, is the world's first ambient touchscreen Wi-Fi router, designed to give users enhanced visibility and control over their home networks through an intuitive interface. The company utilizes advanced wideband hybrid-fiber fixed wireless technology to provide gigabit-capable internet without the constraints of bundles, data caps, or long-term contracts. Starry is committed to prioritizing customer needs, promoting digital equity, and ensuring privacy while delivering fast and reliable internet connectivity. Its products are available for purchase on the company's website and are also offered for pre-order through Amazon Launchpad.

LifeMine Therapeutics

Series C in 2022
LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated platform that combines genomics, artificial intelligence, and synthetic biology. This innovative Avatar-Rx platform utilizes high-throughput microbiology, data science, machine learning, genome engineering, and automation to explore the fungal biosphere for novel genetically encoded molecules with specific biological functions. By integrating chemoinformatic-assisted drug optimization and advanced chemical synthesis with biotransformation, LifeMine Therapeutics aims to advance a pipeline of new medicines into development.

PrognomIQ

Venture Round in 2022
PrognomiQ is a technology company dedicated to advancing early disease detection and treatment, particularly for cancer and other complex diseases. By harnessing multi-omics data, including proteomic, genomic, and metabolomic information, the company aims to enhance understanding and management of health conditions. PrognomiQ's innovative approach allows for the development of advanced medical test products that improve diagnostic capabilities and recurrence monitoring, ultimately seeking to enhance patient outcomes. Through its focus on integrating diverse health data, PrognomiQ is committed to transforming how medical practitioners approach disease detection and treatment.

Menlo Micro

Series C in 2022
Menlo Micro, Inc. specializes in the design and development of electronic switches, particularly through its innovative Ideal Switch technology. This electromechanical switch is capable of handling both AC/DC and RF signals, making it suitable for a range of applications including high-power tunable resonators, filters, broadband power amplifier impedance matching, and electronically steerable antennas. The company's products are utilized in various industries, such as battery management, home automation, electronic vehicles, medical instrumentation, and the industrial Internet of Things, as well as in next generation 5G mobile networks. Founded in 2016 and headquartered in Irvine, California, Menlo Micro aims to enhance the efficiency and performance of advanced systems under high-stress conditions.

Saluda Medical

Private Equity Round in 2022
Saluda Medical, established in 2010, is a global medical device company specializing in neuromodulation technologies. Headquartered in Australia with offices in the US and UK, the company develops and commercializes innovative, closed-loop spinal cord stimulation systems. These systems measure and adapt to the spinal cord's response to stimulation, optimizing therapy within each patient's unique therapeutic window. Saluda's primary focus is treating chronic neuropathic pain, with its devices designed to automatically adjust electrical stimulation based on real-time neurophysiological feedback, tailoring treatment to individual patient needs.

Gousto

Secondary Market in 2022
Gousto is a home meal kit service that delivers fresh, organic, and seasonal ingredients along with curated recipes directly to customers' doorsteps. Founded in 2011 by two friends, the company was born out of a desire to simplify home cooking by providing all the necessary ingredients in the right proportions, eliminating the need for multiple grocery trips. Each week, subscribers can choose from a selection of new recipes developed by a team of professional chefs, ensuring a diverse range of cuisines and styles. Customers have the flexibility to pause their subscription as needed, making it convenient for those with busy lifestyles. Gousto's approach combines quality with ease, enabling individuals and families to prepare delicious and healthy meals at home without the hassle of planning or shopping.

Omada

Series E in 2022
Omada Health, Inc. is a digital healthcare company that specializes in developing online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, California, with an additional office in Atlanta, Georgia, Omada focuses on preventing conditions such as prediabetes, diabetes, hypertension, and heart disease. The company provides personalized digital health programs that cater to the unique needs of individuals, utilizing professional health coaching, connected health devices, and real-time data to facilitate meaningful health improvements. Omada is recognized as the largest provider of the National Diabetes Prevention Program, empowering individuals to engage actively in their health and achieve sustainable lifestyle changes. The platform also addresses behavioral health issues, including anxiety and depression, further supporting individuals in their overall wellness journey.

Somatus

Series E in 2022
Somatus, Inc. is a healthcare company focused on providing specialized kidney care services aimed at delaying or preventing the progression of chronic kidney disease. Founded in 2016 and headquartered in McLean, Virginia, Somatus collaborates with health plans, health systems, nephrology, and primary care groups to deliver integrated care for patients with or at risk of kidney disease. Its comprehensive services include home hemodialysis, peritoneal dialysis, in-center hemodialysis, kidney transplant, and conservative care. By utilizing vertically integrated clinical services and technology, Somatus seeks to improve patient outcomes, enhance care coordination, and promote the use of home dialysis modalities while increasing the rates of kidney transplantation. The company's mission is to ensure that patients can access the care they need to manage kidney disease effectively.

CelLink

Series D in 2022
CelLink Corporation is an innovative company focused on developing flexible conductive backplanes and circuits for power electronics, including applications in batteries, solar panels, light-emitting diodes, and wire harnessing. Founded in 2012 and based in Belmont, California, CelLink manufactures high-conductance, large-area flexible circuits designed to facilitate clean power transmission. Their products integrate essential components such as busing, fusing, and voltage and temperature monitoring into a single circuit, providing customers with efficient solutions for power and data transmission at competitive prices. By offering advanced technology in a growing market, CelLink aims to support the increasing demand for sustainable energy solutions.

Chenjing Tech

Series A in 2022
VR

LeddarTech

Series D in 2022
LeddarTech Inc. is a Canadian company that specializes in developing advanced detection and ranging systems, utilizing time-of-flight measurement technology with infrared LEDs. Its product offerings include smart sensor modules for various applications, such as single-element and multi-element sensor modules, LED-based traffic management sensors, and sensor evaluation kits. These solutions are designed for a wide range of applications, including advanced driver assistance systems (ADAS), autonomous driving, public safety, and industrial monitoring. LeddarTech's flagship platform, LeddarVision™, integrates multiple sensor types to create comprehensive 3D environmental models, facilitating improved perception and navigation capabilities in vehicles. The company aims to address critical sensing challenges for OEMs and automotive suppliers, helping them enhance performance while reducing development time and costs. Founded in 2007 and headquartered in Quebec City, Canada, LeddarTech maintains a research and development office in Toronto and has secured numerous patents in the field of remote sensing technologies.

MNTN

Series D in 2022
MNTN Performance TV is a connected TV advertising platform that specializes in delivering measurable results for marketers through its advanced suite of targeting, measurement, and automated optimization technologies. The company develops a cloud-based advertising platform designed to enhance measurable conversions, revenue, and site visits for clients. It offers an integrated cross-device advertising system that encompasses social, mobile, and display advertising. Key features of the platform include audience segmentation, campaign management, a creative ad builder, and comprehensive reporting tools. This enables marketers and advertisers to maintain complete control and transparency over their campaigns, ensuring that their television advertising initiatives not only meet their goals but also create a lasting business impact.

Capital Markets Gateway

Series B in 2022
Capital Markets Gateway Inc. is a financial technology firm based in Chicago, Illinois, with additional locations in New York and Seattle. Founded in 2015, the company focuses on modernizing equity capital markets by providing a platform that delivers real-time information and analytics to investors, underwriters, and issuers. This platform enables users to monitor capital raising activities, conduct due diligence, and make informed investment decisions while facilitating collaboration among participants. Since its launch in 2017, Capital Markets Gateway has garnered the trust of over 100 buy-side firms, managing a combined $20 trillion in assets under management, along with support from 10 investment banks. The platform emphasizes transparency and workflow efficiencies, serving as a digital system of record for firm-wide deal activity.

Sonder Holdings

Post in 2022
Sonder Canada Inc. specializes in leasing hotel-style apartments to travelers, offering a range of accommodations from rooms to suites and apartments. Founded as Flatbook Corp. and rebranded in 2016, Sonder has expanded its presence across more than 30 cities in eight countries on three continents. The company focuses on delivering a seamless hospitality experience through thoughtfully designed spaces and a tech-powered service model. Its innovative app facilitates self-service features and provides 24/7 support for guests, enhancing convenience and accessibility. Sonder generates revenue by offering both short-term and month-to-month accommodations, with all units carefully selected, designed, and managed by the company.

Bolt

Series F in 2022
Bolt is the first European app with a mission to make cities for people, not cars. Bolt has 100 million customers in 45 countries across Europe and Africa. The company challenges personal car ownership, offering better alternatives for every use case, including ride-hailing, shared cars and scooters, and food and grocery delivery. Bolt was founded in 2013 and is headquartered in Tallinn, Estonia.

Oddity

Venture Round in 2022
ODDITY is a consumer-tech company that builds and scales digital-first brands to disrupt the offline-dominated beauty and wellness industries. The company owns IL MAKIAGE and SpoiledChild.

SalioGen Therapeutics

Series B in 2022
SalioGen Therapeutics is a biotechnology company focused on developing gene therapies for inherited disorders. Utilizing its proprietary Exact DNA Integration Technology (EDIT), the company employs mammal-derived enzymes, known as Saliogase, to facilitate genome engineering. This innovative approach enables the delivery of any size gene through non-viral methods, offering significant advantages in manufacturing and application. SalioGen's technology aims to provide durable, safe, and affordable treatments, potentially transforming the landscape of care for patients with genetic conditions and enhancing the efficiency of cell therapy and biologics manufacturing in the healthcare sector.

DNA Script

Series C in 2022
DNA Script SAS, established in 2014 and headquartered in Paris, France, specializes in synthetic biology tools. The company's core product, SYNTAX, is a revolutionary benchtop DNA printer that uses enzymatic technology to rapidly produce synthetic oligonucleotides, genes, pathways, and genomes. This innovative approach empowers life science researchers and labs to print their own synthetic DNA, enhancing workflow control and accelerating access to results, thereby advancing breakthroughs in life science and human health.

Asoview

Series E in 2021
Asoview is an online booking platform that specializes in providing services for tours, activities, and attractions. The platform allows users to easily book a diverse range of experiences, including water and motorsports, sightseeing tours, horse trekking, cooking classes, and cultural activities. By offering a comprehensive selection of options, Asoview enables individuals to discover and secure reservations for various activities that align with their interests, enhancing their travel experiences.

EQRx

Post in 2021
EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on transforming the drug discovery and delivery process to address the rising costs of medicines. Founded in 2019, EQRx aims to provide a market-based solution by leveraging advances in science and technology while collaborating with various healthcare stakeholders. The company has over ten programs in its pipeline targeting oncology and immune-inflammatory conditions, which include clinical and preclinical stages, as well as drug engineering initiatives. Among its key programs are Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab. Through its innovative approach, EQRx seeks to develop high-quality, patent-protected medicines more efficiently and cost-effectively than traditional pharmaceutical methods.

Cvent

Post in 2021
Cvent is a technology provider focused on enhancing the meetings, events, and hospitality industries through a comprehensive event marketing and management platform. The company offers software solutions that facilitate online event registration, venue selection, event marketing, and management, as well as attendee engagement for various formats, including virtual, hybrid, and onsite events. Cvent's tools are designed to help event planners and marketers optimize the revenue potential of their programs while simplifying the management of each stage in the event lifecycle. By integrating these functionalities, Cvent aims to streamline the planning process and improve overall event effectiveness.

P3 Health Partners

Post in 2021
P3 Health Partners is a patient-centered and physician-led population health management company based in Henderson, Nevada, founded in 2017. The organization focuses on providing primary health care services through a model that aggregates and supports existing healthcare resources in the community. P3 fosters collaboration among community providers to deliver coordinated and integrated care, aiming to improve patient outcomes while reducing costs. The company emphasizes value-based care, leveraging a combination of clinical operations, population health management, and consulting services. By utilizing data, technology, and community outreach, P3 Health Partners seeks to enhance patient experiences and satisfaction for both providers and caregivers.

Local Bounti

Post in 2021
Local Bounti is an agriculture company based in Hamilton, Montana, focused on controlled environment agriculture. Established in 2018, it specializes in producing and delivering fresh herbs, vegetables, and other products primarily to wholesale restaurant and grocery accounts. The company employs proprietary technology to cultivate leafy greens and herbs in innovative greenhouses, which maintain optimal conditions for growth while using less water and land than traditional farming methods. Local Bounti's products are non-GMO, free from herbicides and pesticides, and are designed to have a longer shelf life and superior taste. By building local facilities operated by local teams, the company aims to serve its communities while minimizing its carbon footprint and environmental impact.

Grab

Post in 2021
Grab Holdings Inc., headquartered in Singapore, operates a mobile technology platform that integrates city transportation and various on-demand services in Southeast Asia. The company, founded in 2012 by Anthony Tan and Tan Hooi Ling, offers services such as ride-hailing (GrabTaxi, GrabCar), carpooling (GrabHitch, GrabShare), shuttle services (GrabShuttle, GrabShuttle Plus), and food delivery through its GrabFood platform. Grab also provides financial services, including payments, consumer loans, and enterprise offerings. It operates in eight countries: Singapore, Indonesia, Philippines, Malaysia, Thailand, Vietnam, and Myanmar. Grab generates revenue by charging commissions to both consumers and service providers, with ride-hailing and food delivery contributing to 89% of its total revenue. The company competes with Foodpanda and Gojek in the region.

Innovid

Post in 2021
Innovid is an independent omni-channel advertising and analytics platform designed specifically for television. The company offers a comprehensive software solution that enables advertisers to personalize, deliver, and measure innovative advertising experiences across various devices and media outlets. Its services encompass ad serving, measurement, and creative optimization for TV advertisements, catering to advertisers, publishers, and media agencies. With a strong presence in the U.S., Canada, EMEA, APAC, and LATAM, Innovid focuses on enhancing the effectiveness of TV advertising by providing tools that facilitate the creation and analysis of ads in connected TV, mobile TV, and desktop environments.

Quell Therapeutics

Series B in 2021
Quell's vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions. Quell has been founded by Syncona in partnership with six leading experts in the Treg field, cell engineering, solid organ transplantation and autoimmune diseases: Giovanna Lombardi, Professor of Human Transplant Immunology at Kings College London (KCL), Alberto Sanchez-Fueyo, Professor of Hepatology in the Institute of Liver Studies at KCL, Hans Stauss, Professor of Tumour Immunology and Director of the Institute of Immunity and Transplantation at University College London (UCL), Emma Morris, Professor of Clinical Cell & Gene Therapy and Inflammation, Immunity and Immunotherapeutics Theme Director, National Institute for Health Research University College London Hospitals Biomedical Research Centre, Marc Martinez-Llordella, Senior Lecturer in the Institute of Liver Studies at KCL and Elmar Jaeckel, Co-Leader Liver Transplant program MHH, Group Leader "Immune tolerance" in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School.

GaN Systems

Venture Round in 2021
GaN Systems Inc. is a semiconductor company based in Ottawa, Canada, specializing in the development and manufacturing of gallium nitride power switching transistors. The company offers a variety of products, including 650 V and 100 V E-HEMT transistors and wireless power amplifiers, which are utilized in diverse applications such as consumer electronics, industrial systems, renewable energy sources, and transportation power conversion. GaN Systems aims to address significant challenges in power system efficiency and size limitations, enabling industries to reduce costs and enhance energy efficiency. The company serves a global market, including manufacturers in Japan, Taiwan, and China, with additional offices in Japan, China, and Germany. Established in 2008, GaN Systems continues to innovate in the clean technology power conversion sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.